Coloplast AS - Announcement no. 032023 - Coloplast announces agreement to acquire Kerecis and raises long-term growth expectations - Marketscreener.com
| CBHD Stock | 119.50 1.55 1.28% |
About 61% of Coloplast A/S's investor base is looking to short. The analysis of current outlook of investing in Coloplast AS suggests that many traders are alarmed regarding Coloplast A/S's prospects. The current market sentiment, together with Coloplast A/S's historical and current headlines, can help investors time the market. In addition, many technical investors use Coloplast A/S stock news signals to limit their universe of possible portfolio assets.
Coloplast A/S stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Coloplast daily returns and investor perception about the current price of Coloplast AS as well as its diversification or hedging effects on your existing portfolios.
Coloplast |
Coloplast AS - Announcement no. 032023 - Coloplast announces agreement to acquire Kerecis and raises long-term growth expectations Marketscreener.com
Read at news.google.com
 |
Coloplast A/S Fundamental Analysis
We analyze Coloplast A/S's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Coloplast A/S using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Coloplast A/S based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earnings To Growth
Price To Earnings To Growth Comparative Analysis
Coloplast is rated fourth in price to earnings to growth category among its peers. PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Coloplast A/S Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Coloplast A/S stock to make a market-neutral strategy. Peer analysis of Coloplast A/S could also be used in its relative valuation, which is a method of valuing Coloplast A/S by comparing valuation metrics with similar companies.
Peers
Coloplast A/S Related Equities
| WIQ | Clean Energy | 2.46 | ||||
| ILT | Illinois Tool | 0.54 | ||||
| APC | Apple | 0.46 | ||||
| BAC | Bank of America | 0.24 | ||||
| IZ1 | First Quantum | 0.39 | ||||
| 1YD | Broadcom | 0.62 | ||||
| CBHD | Coloplast A/S | 1.28 | ||||
| CFX | Capital One | 2.20 | ||||
| 43D | Darling Ingredients | 5.44 | ||||
| 8LCA | LendingClub | 6.56 |
Complementary Tools for Coloplast Stock analysis
When running Coloplast A/S's price analysis, check to measure Coloplast A/S's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coloplast A/S is operating at the current time. Most of Coloplast A/S's value examination focuses on studying past and present price action to predict the probability of Coloplast A/S's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coloplast A/S's price. Additionally, you may evaluate how the addition of Coloplast A/S to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |